IL122486A - Process for making liposome preparation - Google Patents

Process for making liposome preparation

Info

Publication number
IL122486A
IL122486A IL12248696A IL12248696A IL122486A IL 122486 A IL122486 A IL 122486A IL 12248696 A IL12248696 A IL 12248696A IL 12248696 A IL12248696 A IL 12248696A IL 122486 A IL122486 A IL 122486A
Authority
IL
Israel
Prior art keywords
liposome preparation
portions
liposome
making liposome
making
Prior art date
Application number
IL12248696A
Other languages
English (en)
Other versions
IL122486A0 (en
Original Assignee
U S Dept Of The Army Medical R
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23888222&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL122486(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by U S Dept Of The Army Medical R filed Critical U S Dept Of The Army Medical R
Publication of IL122486A0 publication Critical patent/IL122486A0/xx
Publication of IL122486A publication Critical patent/IL122486A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
IL12248696A 1995-06-07 1996-06-06 Process for making liposome preparation IL122486A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/475,581 US6007838A (en) 1995-06-07 1995-06-07 Process for making liposome preparation

Publications (2)

Publication Number Publication Date
IL122486A0 IL122486A0 (en) 1998-06-15
IL122486A true IL122486A (en) 2000-07-16

Family

ID=23888222

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12248696A IL122486A (en) 1995-06-07 1996-06-06 Process for making liposome preparation

Country Status (12)

Country Link
US (1) US6007838A (cg-RX-API-DMAC7.html)
EP (1) EP0831779B2 (cg-RX-API-DMAC7.html)
JP (1) JP2000514035A (cg-RX-API-DMAC7.html)
AT (1) ATE203898T1 (cg-RX-API-DMAC7.html)
AU (1) AU699055B2 (cg-RX-API-DMAC7.html)
CA (1) CA2223808A1 (cg-RX-API-DMAC7.html)
DE (1) DE69614385T3 (cg-RX-API-DMAC7.html)
DK (1) DK0831779T4 (cg-RX-API-DMAC7.html)
ES (1) ES2159358T3 (cg-RX-API-DMAC7.html)
IL (1) IL122486A (cg-RX-API-DMAC7.html)
PT (1) PT831779E (cg-RX-API-DMAC7.html)
WO (1) WO1996040063A1 (cg-RX-API-DMAC7.html)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU752802C (en) * 1997-11-14 2006-04-13 Pacira Pharmaceuticals, Inc. Production of multivesicular liposomes
US7115297B2 (en) 2000-02-22 2006-10-03 Suzanne Jaffe Stillman Nutritionally fortified liquid composition with added value delivery systems/elements/additives
US7892586B2 (en) 2001-02-22 2011-02-22 Suzanne Jaffe Stillman Water containing soluble fiber
US8178150B2 (en) 2000-02-22 2012-05-15 Suzanne Jaffe Stillman Water containing soluble fiber
DE60130440D1 (de) 2000-03-21 2007-10-25 Suzanne Jaffe Stillman Aufgussbeutel mit dekorativen gebrauchsmitteln, trägerelementen, abgabevorrichtung und verfahren
US8642051B2 (en) 2000-03-21 2014-02-04 Suzanne Jaffe Stillman Method of hydration; infusion packet system(s), support member(s), delivery system(s), and method(s); with business model(s) and Method(s)
US20040022838A1 (en) * 2001-06-20 2004-02-05 Holick Michael F. Regulation of cell proliferation and differentiation using topically applied peptides
US6852323B2 (en) 2000-07-21 2005-02-08 The Regents Of The University Of California Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder
US7223406B2 (en) * 2000-07-21 2007-05-29 The Regents Of The University Of California Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder
US20040082521A1 (en) * 2002-03-29 2004-04-29 Azaya Therapeutics Inc. Novel formulations of digitalis glycosides for treating cell-proliferative and other diseases
US20030219696A1 (en) * 2002-05-23 2003-11-27 Moreland Gerald W. Method and apparatus for preventing backflow in dental saliva evacuators
EP1519714B1 (en) 2002-06-28 2010-10-20 Protiva Biotherapeutics Inc. Method and apparatus for producing liposomes
CN1674933B (zh) 2002-08-02 2012-09-26 葛兰素史密丝克莱恩生物有限公司 疫苗组合物
JP2006508126A (ja) * 2002-11-06 2006-03-09 アザヤ セラピューティクス インコーポレイティッド 薬学的製剤のタンパク質安定化されたリポソーム製剤
JP5639338B2 (ja) 2005-07-27 2014-12-10 プロチバ バイオセラピューティクス インコーポレイティッド リポソームの製造システムおよび製造方法
WO2007049279A2 (en) * 2005-10-26 2007-05-03 Yissum Research Development Company Of The Hebrew University Of Jerusalem A liposomal combination and uses thereof
ES2337309T5 (es) 2006-06-12 2013-07-30 Glaxosmithkline Biologicals S.A. Vacuna
NO329127B1 (no) * 2006-09-12 2010-08-30 Epitarget As Sporbart partikulaert materiale for legemiddelavlevering omfattende et matriseeller membranmateriale, et legemiddel, og et T1- og et T2*- magnetisk resonanskontrastmiddel
EP2427243A4 (en) 2009-05-05 2012-11-21 Vapogenix Inc NEW FORMULATIONS OF VOLATILE ANESTHETICS AND METHOD OF ADMINISTRATION
WO2011119920A2 (en) 2010-03-25 2011-09-29 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
ES2667425T3 (es) 2011-06-10 2018-05-10 Oregon Health & Science University Glucoproteínas y vectores recombinantes de CMV
EP2586461A1 (en) 2011-10-27 2013-05-01 Christopher L. Parks Viral particles derived from an enveloped virus
EP2679596B1 (en) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 env glycoprotein variant
PL2968214T3 (pl) 2013-03-15 2021-11-02 Newvapogen, Inc. Nowe kompozycje przeciwbólowe
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
EP2873423B1 (en) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
US9392814B2 (en) 2014-06-06 2016-07-19 Nicholas J. Singer Delivery system for drinks
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3072901A1 (en) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
USD773313S1 (en) 2015-06-23 2016-12-06 Nicholas J. Singer Package
PL3615005T3 (pl) 2017-04-28 2025-10-06 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Kompozycje i sposoby dostarczania szczepionki
CN114126600B (zh) * 2020-01-20 2024-03-08 广州谷森制药有限公司 三苯乙酸维兰特罗的脂质体制剂
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12151024B2 (en) 2021-01-22 2024-11-26 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12285419B2 (en) 2021-10-14 2025-04-29 Pacira Pharmaceuticals, Inc. Bupivacaine multivesicular liposome formulations and uses thereof
US12280149B1 (en) 2024-05-20 2025-04-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12251472B1 (en) 2024-05-20 2025-03-18 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12156940B1 (en) 2024-05-20 2024-12-03 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2408387A2 (fr) † 1975-06-30 1979-06-08 Oreal Compositions a base de dispersions aqueuses de spherules lipidiques
AU7128887A (en) * 1986-02-10 1987-08-25 Liposome Technology, Inc. Controlled-release liposome delivery system
US4752425A (en) † 1986-09-18 1988-06-21 Liposome Technology, Inc. High-encapsulation liposome processing method
DE4124252A1 (de) * 1991-07-22 1993-01-28 Knoll Ag Verfahren zur herstellung einer sterilfiltrierbaren wirkstoffloesung
US5631237A (en) † 1992-12-22 1997-05-20 Dzau; Victor J. Method for producing in vivo delivery of therapeutic agents via liposomes
FR2714601B1 (fr) † 1993-12-30 1996-02-09 Oreal Composition dépigmentante pour le traitement simultané des couches superficielles et profondes, son utilisation.

Also Published As

Publication number Publication date
EP0831779B2 (en) 2005-01-19
EP0831779A1 (en) 1998-04-01
AU699055B2 (en) 1998-11-19
WO1996040063A1 (en) 1996-12-19
IL122486A0 (en) 1998-06-15
PT831779E (pt) 2001-11-30
EP0831779B1 (en) 2001-08-08
ES2159358T3 (es) 2001-10-01
JP2000514035A (ja) 2000-10-24
CA2223808A1 (en) 1996-12-19
DE69614385T2 (de) 2002-05-23
AU6036596A (en) 1996-12-30
DE69614385T3 (de) 2005-05-25
DK0831779T3 (da) 2001-10-08
US6007838A (en) 1999-12-28
DK0831779T4 (da) 2005-06-06
ATE203898T1 (de) 2001-08-15
DE69614385D1 (de) 2001-09-13

Similar Documents

Publication Publication Date Title
IL122486A0 (en) Process for making liposome preparation
ES8801118A1 (es) Un metodo para preparar liposomas a base de un fosfolipeno un agente hidratante y un farmaco encapsulado.
GEP20022734B (en) Pharmaceutical Preparation Comprising Lyophilized Liposomes Encapsulating an Active Principle Which Is Highly Insoluble in Water, and the Process for Preparing the Said Preparation
GB2015464B (en) Method of encapsulating biologically active materials in lipid vesicles
HUT55220A (en) Process for producing pharmaceutical composition suitable for systemic administration through the skin and comprising deprenyl as active ingredient
EP0280492A3 (en) Liposome composition and its production
AU4711296A (en) Method for loading lipid vesicles
DK0774959T3 (da) Liposomalt indgivelsessystem for biologisk aktive midler
GR3017147T3 (en) Manufacture and use of stable preparations of small-sized liposomes.
DE2964024D1 (en) Liposomes for drug delivery and composition containing a liposome drug system
NZ503293A (en) Liposomal camptothecin formulations also comprising at least one phospholipid
EP0728476A4 (en) LIPOSOME COMPOSITION
AU3244393A (en) Antibiotic formulation and process
ATE238769T1 (de) Unilamellare liposomenzubereitungen mit hohem wirkstoffanteil
HUT57590A (en) Process for producing liposome compositions comprisings antiandrogenic active ingredient
EP0198765A3 (en) Preparation of liposomes
IL56499A (en) Liposome medicament delivery systems,their preparation and pharmaceutical compositions containing them
HUT62457A (en) Process for producing aqueous liposomal suspensions comprising an active ingredient
GR3036384T3 (en) Medicament form for the delivery of collagenase to wounds and process for the preparation thereof
DK0467275T3 (cg-RX-API-DMAC7.html)
HUT44770A (en) Process for producing 6-phenoxymethyl-4-hydroxy-tetrahydropyran-2-one derivatives and pharmaceutical preparations comprising them as active substance
DE69018258D1 (de) Aktive Bestandteile enthaltende phospholipidische Liposome und Verfahren zu ihrer Herstellung.
AU3564589A (en) Preparation of uniform-size liposomes and other lipid structures
PL287608A1 (en) Method of obtaining stable nitroglycerin dispersion in production of pharmaceutical preparations in particular in the form of tablets
AU4629989A (en) Anti-inflammatory active ingredients for cosmetic preparations

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees